Oak Ridge Investments LLC Uro Gen Pharma Ltd. Transaction History
Oak Ridge Investments LLC
- $1.05 Billion
- Q2 2024
A detailed history of Oak Ridge Investments LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Oak Ridge Investments LLC holds 79,929 shares of URGN stock, worth $997,513. This represents 0.13% of its overall portfolio holdings.
Number of Shares
79,929
Previous 61,204
30.59%
Holding current value
$997,513
Previous $918,000
46.08%
% of portfolio
0.13%
Previous 0.09%
Shares
2 transactions
Others Institutions Holding URGN
# of Institutions
119Shares Held
39.3MCall Options Held
158KPut Options Held
161K-
Rtw Investments, LP New York, NY3.56MShares$44.4 Million1.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA3.3MShares$41.2 Million0.11% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.08MShares$38.5 Million0.78% of portfolio
-
Great Point Partners LLC Greenwich, CT2.91MShares$36.3 Million12.93% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct2.45MShares$30.6 Million0.11% of portfolio
About UroGen Pharma Ltd.
- Ticker URGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 22,740,500
- Market Cap $284M
- Description
- UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...